BullFrog AI Holdings, Inc., a technology-driven drug development company, has announced the identification of multiple potential therapeutic targets for colorectal…
Browsing: Hot headlines in GI
TOPLINE:Research from Korea provides additional evidence for the connection between COVID-19 and an increased risk for autoimmune conditions post-infection. METHODOLOGY:
CHICAGO— Up to 45% of species in the gut microbiome show substantial diurnal, seasonal and regional variations at the population…
The ColoAlert test, developed by Mainz Biomed, is an at-home diagnostic tool designed to detect colorectal cancer early. While colonoscopies…
In a study presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting, researchers showcased the efficacy of two…
All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health…
Health insurance company Cigna has agreed to pay over $172 million to settle federal allegations that it knowingly submitted false…
The FDA has granted de novo clearance to ProciseDx Inc. for its therapeutic drug monitoring tests for Humira and Remicade,…
Alcohol-associated liver disease, one of the most common types of liver disease worldwide, is associated with tremendous morbidity, mortality, and…
A recent study has found that the use of glucagon-like peptide 1 (GLP-1) agonists for weight loss, when compared with…